Efficacia del Levetiracetam a lungo termine nel trattamento delle epilessie sintomatiche farmacoresistenti

Translated title of the contribution: Efficacy of Levetiracetam in the long-term treatment of drug-resistant symptomatic epilepsies

M. Elia, M. Bottitta, G. Calabrese, S. Romano, S. A. Musumeci

Research output: Contribution to journalArticlepeer-review

Abstract

In this open label study we evaluated the efficacy of Levetiracetam (LEV) in the long-term treatment of 15 patients (7 males, 8 females, age range 4-40 years, mean 22.53 years) with drug-resistant symptomatic epilepsies. Our data showed that LEV is an efficacious and safe antieplleptic drug in this group of subjects.

Translated title of the contributionEfficacy of Levetiracetam in the long-term treatment of drug-resistant symptomatic epilepsies
Original languageItalian
Pages (from-to)197-199
Number of pages3
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number129-130
Publication statusPublished - 2005

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Efficacy of Levetiracetam in the long-term treatment of drug-resistant symptomatic epilepsies'. Together they form a unique fingerprint.

Cite this